Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.091 USD | -3.11% | -15.55% | +8.83% |
05-09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
04-17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.83% | 121M | |
+4.00% | 111B | |
+11.42% | 105B | |
-13.01% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.44% | 13.7B | |
+36.07% | 12.45B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- Oppenheimer Downgrades DiaMedica Therapeutics to Market Perform From Outperform